Latest News Archive
Please select Category, Year, and then Month to display items
31 January 2024
|
Story EDZANI NEPHALELA
|
Photo ANJA AUCAMP
Dr Martin Laubscher’s thesis, crowned with the Andrew Murray-Desmond Tutu Prize, is testament to the university’s unwavering commitment to scholarly excellence.
In a historic triumph that reverberates over four decades since its inception, the UFS has clinched the coveted
Andrew Murray Prize – now renamed the Andrew Murray-Desmond Tutu Prize – for the first time. Standing shoulder to shoulder with institutions such as the University of Pretoria (UP) and Stellenbosch University (SU), this achievement marks a significant milestone in the UFS’ journey.
At the heart of this accomplishment lies the profound contribution of
Dr Martin Laubscher, distinguished Senior Lecturer specialising in Practical and Missional Theology in the
Faculty of Theology and Religion. Dr Laubscher’s dedication and scholarly prowess culminated in the groundbreaking work titled
Publieke teologie as profetiese teologie? (Public theology as prophetic theology), a revised edition of his doctoral thesis, which was originally crafted at Stellenbosch University in 2020, with a focus on the eminent Karl Barth.
Dr Laubscher received the Andrew Murray Prize for Theological Books in Afrikaans for his research and insightful analysis. The journey started when he realised, under the guidance of his study leader,
Prof Dion Forster, that his script had the potential to be published in Afrikaans. Sun Media’s interest in publishing this work in Afrikaans, led to it being the first-ever published thesis in Afrikaans. Dr Laubscher recalls, “I was grateful and excited about Sun Media’s interest. The book emerged within a year, and during a celebratory launch Prof Forster suggested I submit it for the Andrew Murray Prize.”
Earlier this year, Dr Laubscher was excited to learn that he was being shortlisted for the prestigious award. Reflecting on the significant moment, he shares, “The elation I felt upon receiving the news was unparalleled. I was not only celebrating a personal triumph, but also etching my name as the first laureate from our faculty to secure this prestigious accolade.”
UFS Expert: Prof Felicity Burt investigates zoonotic and arboviruses
2017-12-13
Prof Felicity Burt recently received a B-rating from the
National Research
Foundation.
Photo: Sonia Small
Prof Felicity Burt is from the Division of Virology in the Faculty of Health Sciences at the University of the Free State (UFS), as well as the National Health Laboratory Services (NHLS). She currently holds an NRF-DST South African Research Chair in vector-borne and zoonotic diseases. Professor Burt and her research group investigate arboviruses and zoonotic viruses.
Prof Burt’s research primarily focuses on host immune responses to arboviral infections specifically characterising humoral and cellular immune responses in patients with infections such as Crimean-Congo haemorrhagic fever (CCHF) virus and Sindbis virus; epitope discovery for development of diagnostic tools; development of molecular and serological assays for surveillance purposes; virus discovery; and the development of vaccines.
Raising awareness of these viruses, defining associated diseases, and developing tools for surveillance programmes will contribute to understanding these pathogens as well as the public health implications.
Leads research group in papilloma viruses
Arboviruses cause outbreaks of disease in South Africa annually. Outbreaks are usually associated with heavy rainfall favouring the breeding of mosquitos, but these viruses also have the capacity to spread and become endemic in new areas where competent vectors are present.
In addition, she is leading a research group that investigates human papilloma viruses (HPV) associated with head and neck cancers and recurrent laryngeal papilloma.
The focus of this research group is to ascertain the genotypes of HPV causing these diseases, identification of novel biomarkers for early detection, and complete genome sequencing for molecular characterisation of HPV isolates.